Mindray Medical International Limited (NYSE:MR)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of medical devices in China.

Recs

0
Player Avatar quietnews (38.68) Submitted: 12/1/2010 11:37:23 AM : Outperform Start Price: $25.63 MR Score: +10.77

I'm in China often. The level of medical care needs strong infrastructure improvement, including equipment. I'm surprised the China government hasn't put this as one of their very high priorities. MR will be poised to take advantage when this focus happens.

Featured Broker Partners


Advertisement